FindTrial
Sign In

relation of clinical symptoms of pain and heavy menstrual bleeding in adenomyosis with ultrasound features as mentioned in revised Morphological Ultrasonographic Assessment (MUSA) features

Correlation of clinical manifestations of adenomyosis with revised Morphological Ultrasonographic Assessment (MUSA) features. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060484
Enrollment
107
Registered
2023-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N858- Other specified noninflammatory disorders of uterus

Interventions

None listed

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with symptoms of dysmenorrhea/HMB/ and Diagnosed to have adenomyosis based on ? 1 ultrasound features of adenomyosis as per revised MUSA criteria Willing to give informed written consent

Exclusion criteria

Exclusion criteria: Coexisting fibroid (Fibroid >5 cm or FIGO type 0,1,2) Coexisting endometriosis Women using contraceptives or taking hormonal medications within 3 months of recruitment Not willing to give consent for the study

Design outcomes

Primary

MeasureTime frame
1.Correlation of pain score (NRS4) with direct/indirect features, number of features, site and extent of adenomyosis 2.Correlation of total menstrual loss by PBAC(PBAC100) with direct/indirect features, number of features, site and extent of adenomyosis Timepoint: patient assessment at a given point only, no follow up required—

Secondary

MeasureTime frame
1. To correlate type of feature, number of features, site and extent of adenomyosis with quality of lifeTimepoint: zero weeks—

Countries

India

Contacts

Public ContactJuhi Bharti

AIIMS New Delhi

drjuhigeorgian.04@gmail.com8527570849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026